Covaxin Junior: Bharat Biotech’s kids’ vaccine is good news. But why is its vaccine for adults yet to get WHO clearance?

Covaxin Junior: Bharat Biotech’s kids’ vaccine is good news. But why is its vaccine for adults yet to get WHO clearance? Bharat Biotech is on the threshold of becoming the second Indian vaccine maker to receive an emergency use approval in the domestic market for a children’s Covid vaccine. The company’s vaccine, Covaxin, is already in use in the national programme. It’s supplied about 111 million doses, or 11. https://ift.tt/eA8V8J